首页 > 市场调查报告书 > 医疗设备

体外诊断癌症癌症诊断

市场调查报告书

商品编码

1386474

甲状腺癌诊断市场报告：2030 年趋势、预测与竞争分析

Thyroid Cancer Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: 2023年10月11日 | 出版商:

Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

甲状腺癌诊断的趋势和预测

预计到 2030 年，全球甲状腺癌诊断市场将达到 76 亿美元，2024 年至 2030 年年复合成长率为 5.5%。该市场的主要驱动因素是甲状腺癌盛行率的增加、对即时诊断和治疗的日益关注以及对甲状腺癌的认识不断提高。全球甲状腺癌诊断市场前景广阔，医院、附属实验室、独立诊断实验室、诊断影像中心和癌症研究实验室市场存在商机。

甲状腺癌诊断市场洞察

Lucintel 预测，由于对高解析度和即时影像检查的需求不断增加，影像检查仍将是最大的细分市场。

在这个市场中，由于医院诊断癌症患者数量的增加、消费者意识的提高以及对全球医疗基础设施投资的增加，医院在预测期内将继续成为最大的细分市场。

由于美国甲状腺癌盛行率不断上升、医疗保健支出增加以及政府在认识、诊断和治疗方面的积极配合措施，美国可能仍然是最大的地区。

本报告回答了 11 个关键问题：

Q.1. 细分市场中最有前途和高成长的机会是什么？
Q.2.哪个细分市场将以更快的速度成长？为什么？
Q.3.您认为哪些地区未来会出现更快的成长？为什么？
Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和业务风险是什么？
Q.5. 这个市场的商业风险和竞争威胁是什么？
Q.6.这个市场有哪些新趋势？为什么？
Q.7.市场客户需求有何改变？
Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

宏观经济趋势（2018-2023）与预测（2024-2030）
全球甲状腺癌诊断市场趋势（2018-2023）与预测（2024-2030）
按产品类型分類的全球甲状腺癌诊断市场
- 装置
- 消耗品及配件
按测试类型分類的全球甲状腺癌诊断市场
- 影像检查
- 切片检查
- 验血
- 其他的
按最终用途分類的全球甲状腺癌诊断市场
- 医院
- 相关研究所
- 独立诊断实验室
- 影像诊断中心
- 癌症研究所
- 其他的

第4章2018-2030年分地区市场趋势及预测分析

按地区分類的全球甲状腺癌诊断市场
北美甲状腺癌诊断市场
欧洲甲状腺癌诊断市场
亚太甲状腺癌诊断市场
其他地区甲状腺癌诊断市场

第5章竞争分析

产品系列分析
营运整合
波特五力分析

第6章成长机会与策略分析

成长机会分析
- 按产品类型分類的全球甲状腺癌诊断市场成长机会
- 按测试类型分類的全球甲状腺癌诊断市场成长机会
- 全球甲状腺癌诊断市场最终用途的成长机会
- 全球甲状腺癌诊断市场按地区成长机会
全球甲状腺癌诊断市场新趋势
战略分析
- 新产品开发
- 扩大全球甲状腺癌诊断市场的能力
- 全球甲状腺癌诊断市场的合併、收购与合资企业
- 认证和许可

第7章主要企业概况

Abbott
Hoffmann-La Roche
Thermo Fisher Scientific
Siemens Healthcare
Bio-Rad Laboratories
General Electric
Koninklijke Philips
Toshiba Corporation
Agilent Technologies
Illumina

简介目录

Thyroid Cancer Diagnostic Trends and Forecast

The future of the global thyroid cancer diagnostic market looks promising with opportunities in the hospital, associated lab, independent diagnostic laboratory, diagnostic imaging center, and cancer research institute markets. The global thyroid cancer diagnostic market is expected to reach an estimated $7.6 billion by 2030 with a CAGR of 5.5% from 2024 to 2030. The major drivers for this market are the increasing incidence of thyroid cancer, growing focus on real time diagnosis and treatment, and rising awareness towards thyroid cancer.

A more than 150-page report is developed to help in your business decisions.

Thyroid Cancer Diagnostic by Segment

The study includes a forecast for the global thyroid cancer diagnostic by product type, test type, end use, and region.

Thyroid Cancer Diagnostic Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

Instruments
Consumables & Accessories

Thyroid Cancer Diagnostic Market by Test Type [Shipment Analysis by Value from 2018 to 2030]:

Imaging Test
Biopsy
Blood Test
Others

Thyroid Cancer Diagnostic Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

Hospital
Associated Labs
Independent Diagnostic Laboratories
Diagnostic Imaging Centers
Cancer Research Institutes
Others

Thyroid Cancer Diagnostic Market by Region [Shipment Analysis by Value from 2018 to 2030]:

North America
Europe
Asia Pacific
The Rest of the World

List of Thyroid Cancer Diagnostic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies thyroid cancer diagnostic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the thyroid cancer diagnostic companies profiled in this report include-

Abbott
Hoffmann-La Roche
Thermo Fisher Scientific
Siemens Healthcare
Bio-Rad Laboratories
General Electric
Koninklijke Philips
Toshiba Corporation
Agilent Technologies
Illumina

Thyroid Cancer Diagnostic Market Insights

Lucintel forecasts that imaging test will remain the largest segment due to the increasing demand of high resolution and real time image testing.

Within this market, hospitals will remain the largest segmnt over the forecast period due to growing inflow of cancer diagnosis patient in hospitals, increasing consumer awareness, and growing investments in healthcare infrastructure across the globe.

North America will remain the largest region due to increasing prevalence of thyroid cancer, rising healthcare expenditure, and favourable government initiative in the US for awareness, diagnostic and treatment.

Features of the Global Thyroid Cancer Diagnostic Market

Market Size Estimates: Thyroid cancer diagnostic market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Thyroid cancer diagnostic market size by product type, test type, end use, and region in terms of value ($B).

Regional Analysis: Thyroid cancer diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, test types, end uses, and regions for the thyroid cancer diagnostic market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the thyroid cancer diagnostic market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the thyroid cancer diagnostic market size?

Answer: The global thyroid cancer diagnostic market is expected to reach an estimated $7.6 billion by 2030.

Q.2 What is the growth forecast for thyroid cancer diagnostic market?

Answer: The global thyroid cancer diagnostic market is expected to grow with a CAGR of 5.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the thyroid cancer diagnostic market?

Answer: The major drivers for this market are the increasing incidence of thyroid cancer, growing focus on real time diagnosis and treatment, and rising awareness towards thyroid cancer.

Q4. What are the major segments for thyroid cancer diagnostic market?

Answer: The future of the thyroid cancer diagnostic market looks promising with opportunities in the hospital, associated lab, independent diagnostic laboratory, diagnostic imaging center, and cancer research institute markets.

Q5. Who are the key thyroid cancer diagnostic market companies?

Answer: Some of the key thyroid cancer diagnostic companies are as follows:

Abbott
Hoffmann-La Roche
Thermo Fisher Scientific
Siemens Healthcare
Bio-Rad Laboratories
General Electric
Koninklijke Philips
Toshiba Corporation
Agilent Technologies
Illumina

Q6. Which thyroid cancer diagnostic market segment will be the largest in future?

Answer: Lucintel forecasts that imaging test will remain the largest segment due to the increasing demand of high resolution and real time image testing.

Q7. In thyroid cancer diagnostic market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to increasing prevalence of thyroid cancer, rising healthcare expenditure, and favourable government initiative in the US for awareness, diagnostic and treatment.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the thyroid cancer diagnostic market by product type (instruments and consumables & accessories), test type (imaging test, biopsy, blood test, and others), end use (hospital, associated labs, independent diagnostic laboratories, diagnostic imaging centers, cancer research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

1. Executive Summary

2. Global Thyroid Cancer Diagnostic Market : Market Dynamics

2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Thyroid Cancer Diagnostic Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Thyroid Cancer Diagnostic Market by Product Type
- 3.3.1: Instruments
- 3.3.2: Consumables & Accessories
3.4: Global Thyroid Cancer Diagnostic Market by Test Type
- 3.4.1: Imaging Test
- 3.4.2: Biopsy
- 3.4.3: Blood Test
- 3.4.4: Others
3.5: Global Thyroid Cancer Diagnostic Market by End Use
- 3.5.1: Hospital
- 3.5.2: Associated Labs
- 3.5.3: Independent Diagnostic Laboratories
- 3.5.4: Diagnostic Imaging Centers
- 3.5.5: Cancer Research Institutes
- 3.5.6: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

4.1: Global Thyroid Cancer Diagnostic Market by Region
4.2: North American Thyroid Cancer Diagnostic Market
- 4.2.1: North American Thyroid Cancer Diagnostic Market by Test Type: Imaging Test, Biopsy, Blood Test, and Others
- 4.2.2: North American Thyroid Cancer Diagnostic Market by End Use: Hospital, Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes, and Others
4.3: European Thyroid Cancer Diagnostic Market
- 4.3.1: European Thyroid Cancer Diagnostic Market by Test Type: Imaging Test, Biopsy, Blood Test, and Others
- 4.3.2: European Thyroid Cancer Diagnostic Market by End Use: Hospital, Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes, and Others
4.4: APAC Thyroid Cancer Diagnostic Market
- 4.4.1: APAC Thyroid Cancer Diagnostic Market by Test Type: Imaging Test, Biopsy, Blood Test, and Others
- 4.4.2: APAC Thyroid Cancer Diagnostic Market by End Use: Hospital, Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes, and Others
4.5: ROW Thyroid Cancer Diagnostic Market
- 4.5.1: ROW Thyroid Cancer Diagnostic Market by Test Type: Imaging Test, Biopsy, Blood Test, and Others
- 4.5.2: ROW Thyroid Cancer Diagnostic Market by End Use: Hospital, Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes, and Others

5. Competitor Analysis

5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

6.1: Growth Opportunity Analysis
- 6.1.1: Growth Opportunities for the Global Thyroid Cancer Diagnostic Market by Product Type
- 6.1.2: Growth Opportunities for the Global Thyroid Cancer Diagnostic Market by Test Type
- 6.1.3: Growth Opportunities for the Global Thyroid Cancer Diagnostic Market by End Use
- 6.1.4: Growth Opportunities for the Global Thyroid Cancer Diagnostic Market by Region
6.2: Emerging Trends in the Global Thyroid Cancer Diagnostic Market
6.3: Strategic Analysis
- 6.3.1: New Product Development
- 6.3.2: Capacity Expansion of the Global Thyroid Cancer Diagnostic Market
- 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Thyroid Cancer Diagnostic Market
- 6.3.4: Certification and Licensing